Clostridium-Butyricum-Capsule
Description
- 产品描述
-
Clostridium Butyricum Capsule
BAOTAI (HANGZHOU) PHARMACEUTICAL CO., LTDStrength — artwork
200 mg per capsulePack configuration — artwork
6 capsules/blister × 3 blisters/box; 18 capsules/boxDosage form
Oral capsules containing white or off-white powder.Composition / viable count
Live Clostridium butyricum; at least 1 × 10⁷ CFU per capsule throughout shelf life.Indication
Acute diarrhea caused by intestinal flora imbalance.Administration
Adults: two capsules orally, three times daily, for 4–14 days. Children under 12: one capsule three times daily. Infants: follow medical advice. Take with cool or lukewarm water.Safety summary
The cited leaflet reports no evident adverse reactions and no specific contraindications; this does not establish absence of risk. Pregnancy and lactation data are not established. Avoid simultaneous antibiotic administration because efficacy may decrease. Protect from moisture and heat after opening.Storage / shelf life
Store below 25°C in a dry place, protected from light. Shelf life: 24 months from preparation of the intermediate product.
DOCUMENT STATUS
Product information matched to packaging artwork. BAOTAI specifications and regulatory status remain subject to confirmation; this document is not an approved prescribing leaflet.
FAQs
What main products does Baotai Pharmaceutical supply?
Which countries and regions do you mainly export to?
Does your company have international GMP qualification support?
Can you help complete local drug registration in target countries?
What therapeutic areas do your human medicines focus on?
Do you cooperate with formal domestic pharmaceutical manufacturers?
Clostridium-Butyricum-Capsule
OUR SERVICE
We offers a wealth of product support resources, including a range of technical and downloadable product manuals to product certifications.
Documentation Contact UsRelated Products
The content is currently being updated……